The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background
Associations between patient‐reported outcomes and dose to organs at risk (OARs) may promote management and guide future investigations.
Methods
We retrospectively evaluated PROs and OAR dose in head and neck (H&N) cancer.
Results
In 169 patients, we identified weak associations between: “Difficulty swallowing/chewing” and increased mean RT dose to the oral cavity, larynx, pharyngeal...
Background
Patient Reported Outcome (PRO) data comparing bolus (B‐CP) with weekly (W‐CP) cisplatin concurrent with radiation are lacking.
Methods
We performed a retrospective study comparing PRO among 99 patients with head and neck radiation, 26% who received concurrent B‐CP and 73% treated with W‐CP.
Results
W‐CP patients had a higher Charlson comorbidity index (CCI) (P = .004). There were no...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.